Prudential Financial’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $96.9K | Buy |
+10,350
| New | +$96.9K | ﹤0.01% | 2288 |
|
|
2024
Q4 | – | Sell |
-38,290
| Closed | -$737K | – | 2653 |
|
|
2024
Q3 | $737K | Sell |
38,290
-96,140
| -72% | -$1.85M | ﹤0.01% | 2044 |
|
|
2024
Q2 | $2.76M | Buy |
134,430
+118,670
| +753% | +$2.44M | ﹤0.01% | 1231 |
|
|
2024
Q1 | $375K | Buy |
+15,760
| New | +$375K | ﹤0.01% | 2267 |
|
|
2023
Q4 | – | Sell |
-134,470
| Closed | -$2.1M | – | 2710 |
|
|
2023
Q3 | $2.1M | Sell |
134,470
-34,300
| -20% | -$535K | ﹤0.01% | 1336 |
|
|
2023
Q2 | $3.53M | Sell |
168,770
-16,935
| -9% | -$354K | 0.01% | 1084 |
|
|
2023
Q1 | $3.92M | Buy |
185,705
+46,030
| +33% | +$972K | 0.01% | 974 |
|
|
2022
Q4 | $3.55M | Buy |
139,675
+34,005
| +32% | +$865K | 0.01% | 1021 |
|
|
2022
Q3 | $2.54M | Buy |
+105,670
| New | +$2.54M | ﹤0.01% | 1189 |
|
|
2020
Q3 | – | Sell |
-13,170
| Closed | -$195K | – | 2469 |
|
|
2020
Q2 | $195K | Sell |
13,170
-12,138
| -48% | -$180K | ﹤0.01% | 2272 |
|
|
2020
Q1 | $278K | Sell |
25,308
-2,050
| -7% | -$22.5K | ﹤0.01% | 2090 |
|
|
2019
Q4 | $240K | Sell |
27,358
-200
| -0.7% | -$1.76K | ﹤0.01% | 2280 |
|
|
2019
Q3 | $206K | Buy |
27,558
+6,448
| +31% | +$48.2K | ﹤0.01% | 2313 |
|
|
2019
Q2 | $197K | Buy |
+21,110
| New | +$197K | ﹤0.01% | 2346 |
|